ThermoGenesis Holdings, Inc. is a California-based company that develops and markets automated technologies for cell-based therapies. Their suite of solutions includes a semi-automated CAR-TXpress platform, which simplifies the manufacturing process for the emerging CAR-T immunotherapy market, and systems for cell isolation, washing, and purification. ThermoGenesis Holdings, Inc. also manufactures automated systems for cord blood samples and cell therapeutic products used in clinical applications.